Literature DB >> 3540080

Further evidence that insulin metabolism is a major determinant of peripheral insulin response to oral glucose in subjects with mild glucose intolerance.

E Bonora, I Zavaroni, V Manicardi, C Coscelli, U Butturini.   

Abstract

In mild glucose intolerance plasma concentration of C-peptide seems to give an estimate of pancreatic B cell secretion more reliable than plasma insulin itself. In the present study we measured the plasma levels of insulin and C-peptide after oral glucose load in 100 mildly glucose intolerant subjects, focusing our attention on high and low insulin responders. According to an insulin incremental area after oral glucose higher or lower than the mean +/- SD of the mean, 16 subjects were classified as "high insulin responders", and 17 as "low insulin responders". The two groups were similar for sex, age and bw. Mean insulin incremental area was almost 9-fold greater in high insulin responders than in low insulin responders (0.88 +/- 0.03 vs 0.10 +/- 0.01 pmol/ml min, p less than 0.001). Also mean C-peptide incremental area was significantly greater in high insulin responders than in low insulin responders, but the differences between the two groups were smaller. Indeed, mean C-peptide area was approximately 2.5-fold greater in high insulin responders than in low insulin responders (1.58 +/- 0.12 vs 0.66 +/- 0.07 pmol/ml min, p less than 0.001). These results give further support to the concept that in mild glucose intolerance insulin metabolism is a major determinant of peripheral insulin response to oral glucose load.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3540080     DOI: 10.1007/BF03346945

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  15 in total

1.  Immunoassay of insulin with insulin-antibody precipitate.

Authors:  C N HALES; P J RANDLE
Journal:  Biochem J       Date:  1963-07       Impact factor: 3.857

2.  Immunoassay of endogenous plasma insulin in man.

Authors:  R S YALOW; S A BERSON
Journal:  J Clin Invest       Date:  1960-07       Impact factor: 14.808

3.  Insulin-independent diabetes mellitus: metabolic characteristics.

Authors:  G M Reaven
Journal:  Metabolism       Date:  1980-05       Impact factor: 8.694

4.  C-peptide and insulin secretion. Relationship between peripheral concentrations of C-peptide and insulin and their secretion rates in the dog.

Authors:  K S Polonsky; W Pugh; J B Jaspan; D M Cohen; T Karrison; H S Tager; A H Rubenstein
Journal:  J Clin Invest       Date:  1984-11       Impact factor: 14.808

5.  Kinetics of human connecting peptide in normal and diabetic subjects.

Authors:  O K Faber; C Hagen; C Binder; J Markussen; V K Naithani; P M Blix; H Kuzuya; D L Horwitz; A H Rubenstein; N Rossing
Journal:  J Clin Invest       Date:  1978-07       Impact factor: 14.808

6.  Hepatic disposal of biosynthetic human insulin and porcine C-peptide in humans.

Authors:  P R Bratusch-Marrain; W K Waldhäusl; S Gasić; A Hofer
Journal:  Metabolism       Date:  1984-02       Impact factor: 8.694

7.  Splanchnic and renal metabolism of insulin in human subjects: a dose-response study.

Authors:  E Ferrannini; J Wahren; O K Faber; P Felig; C Binder; R A DeFronzo
Journal:  Am J Physiol       Date:  1983-06

8.  Metabolism of C-peptide in the dog. In vivo demonstration of the absence of hepatic extraction.

Authors:  K Polonsky; J Jaspan; W Pugh; D Cohen; M Schneider; T Schwartz; A R Moossa; H Tager; A H Rubenstein
Journal:  J Clin Invest       Date:  1983-09       Impact factor: 14.808

Review 9.  C-peptide.

Authors:  J B Hoekstra; H J van Rijn; D W Erkelens; J H Thijssen
Journal:  Diabetes Care       Date:  1982 Jul-Aug       Impact factor: 19.112

Review 10.  Insulin degradation by insulin target cells.

Authors:  B J Goldstein; J N Livingston
Journal:  Metabolism       Date:  1981-08       Impact factor: 8.694

View more
  3 in total

1.  Studies on the mechanism of action of sulphonylureas in type II diabetic subjects: gliquidone.

Authors:  E Bonora; P Moghetti; M Querena; M Zenere; V Cacciatori; F Tosi; D Travia; G Zoppini; M Muggeo
Journal:  J Endocrinol Invest       Date:  1992-01       Impact factor: 4.256

2.  Impaired Glucose and Insulin Homeostasis in Moderate-Severe CKD.

Authors:  Ian H de Boer; Leila Zelnick; Maryam Afkarian; Ernest Ayers; Laura Curtin; Jonathan Himmelfarb; T Alp Ikizler; Steven E Kahn; Bryan Kestenbaum; Kristina Utzschneider
Journal:  J Am Soc Nephrol       Date:  2016-01-28       Impact factor: 10.121

Review 3.  Targeting Insulin-Degrading Enzyme in Insulin Clearance.

Authors:  Malcolm A Leissring; Carlos M González-Casimiro; Beatriz Merino; Caitlin N Suire; Germán Perdomo
Journal:  Int J Mol Sci       Date:  2021-02-24       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.